PBMs Want Separate FTC Hearings Over Insulin Prices

By Matthew Perlman · October 24, 2024, 6:39 PM EDT

Caremark Rx LLC, Express Scripts Inc. and OptumRx Inc. are calling for separate proceedings in the Federal Trade Commission's case accusing the pharmacy benefit managers of artificially inflating insulin prices through...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Recent Articles By Matthew

October 21, 2024
NC Justices Revive Challenge To Hospital Competition Law
October 15, 2024
FTC Wants More Info On $1.36B Home Healthcare Deal
October 07, 2024
Justices Won't Hear Shkreli's Bid To Undo $64M Disgorgement
September 23, 2024
Medical Records Co. Accused Of Blocking Data Access
September 20, 2024
FTC Accuses Drug Middlemen Of Raising Insulin Prices
September 05, 2024
FTC Staff Opposes Indiana Hospital Merger
September 03, 2024
Gov't Backs 9th Circ. Bid To Revive Invisalign Monopoly Case
August 16, 2024
Calif. State Court Tosses Antitrust Case Against MultiPlan
August 16, 2024
5th Circ. Tosses Appeal In FTC's Anesthesia Antitrust Case
August 13, 2024
Anesthesia Co. Says FTC Lacks Authority To Bring 'Rollup' Suit